Brainstorm Cell Therapeutics Inc. (BCLI)
OTCMKTS · Delayed Price · Currency is USD
0.9900
-0.0100 (-1.00%)
At close: Nov 13, 2026
Brainstorm Cell Therapeutics Employees
Brainstorm Cell Therapeutics had 19 employees as of June 30, 2026. The number of employees decreased by 10 or 34.48% compared to the same quarter last year. That makes Brainstorm Cell Therapeutics the 38,630th largest employer in the world and 5,557th in the United States.
Employees
19
Change (1Y)
-10
Growth (1Y)
-34.48%
Revenue / Employee
n/a
Profits / Employee
-$553,789
Market Cap
14.12M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Inhibitor Therapeutics | 8 |
| ZIVO Bioscience | 7 |
| Provectus Biopharmaceuticals | 6 |
| Anebulo Pharmaceuticals | 3 |
| Hepion Pharmaceuticals | 2 |
| Vicapsys Life Sciences | 2 |
| Synlogic | 1 |
Brainstorm Cell Therapeutics News
- 2 months ago - BrainStorm Executive Leadership to Participate in DUPHAT 2026; Executive Chairman Peter J. Pitts Invited to Deliver Two Keynote Addresses and Moderate Panel Sessions - PRNewsWire
- 2 months ago - Brainstorm Cell Therapeutics Earnings release: Q2 2026 - Filings
- 2 months ago - Brainstorm Cell Therapeutics Quarterly report: Q2 2026 - Filings
- 3 months ago - BrainStorm Cell Therapeutics Announces Second Quarter 2026 Financial Results and Provides Corporate Update - PRNewsWire
- 3 months ago - BrainStorm Appoints Former FDA Associate Commissioner Peter J. Pitts as Executive Chairman - PRNewsWire
- 5 months ago - BrainStorm Cell Therapeutics Announces Publication Calling for Updated FDA Approaches to ALS, Rare Diseases and Regenerative Medicine - PRNewsWire
- 5 months ago - Lunai Bioworks and BrainStorm launch foundation for neurological diseases - TheFly
- 5 months ago - BrainStorm Cell Therapeutics Appoints Former FDA Associate Commissioner Peter J. Pitts to Board of Directors - PRNewsWire